Escobar-Munguía Ignacio, Berea-Baltierra Ricardo, Morales-González Ángel, Madrigal-Santillán Eduardo, Anguiano-Robledo Liliana, Morales-González José A
Jefe del Departamento de Medicina Interna y Apoyo Nutricio, Hospital de Oncología, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS) México.
Especialista en Medicina Interna, Hospital Juárez de México México.
Am J Cancer Res. 2022 Jul 15;12(7):3294-3302. eCollection 2022.
Colorectal cancer (CRC) is found among those with greatest frequency and exponential increase worldwide, with high mortality rates, which are observed as increasing due to the postsurgical complications that come to present. Systemic inflammation participates in the development and progression of cancer; therefore, inflammatory and/or immunological response markers such as the neutrophil/lymphocyte index (NLI) can aid us in predicting the poor results of our interventions. The purpose of our study was to determine the impact of an NLI of ≥2.6 as a predictor of early postsurgical complications. By means of a prospective cohort, we analyzed 158 patients with CRC who were submitted to elective surgery with a later 30-day follow-up. We found that the preoperatory NLI of ≥2.6 obtained an odds ratio (OR) = 2.24 (95% confidence interval [CI], 1.15-4.36) as a prognostic factor of early postsurgical complications according to the Clavien-Dindo classification scale, which represents a low prognostic impact due to its predictive yield with low accuracy, which is the opposite of what other reports have previously published. The use of chemotherapy before the surgical procedure was also determined to be a risk factor for post-surgical complications.
结直肠癌(CRC)在全球范围内发病率最高且呈指数增长,死亡率高,术后并发症导致死亡率不断上升。全身炎症参与癌症的发生和发展;因此,中性粒细胞/淋巴细胞指数(NLI)等炎症和/或免疫反应标志物可帮助我们预测干预效果不佳。我们研究的目的是确定NLI≥2.6作为早期术后并发症预测指标的影响。通过前瞻性队列研究,我们分析了158例接受择期手术并进行30天随访的CRC患者。我们发现,根据Clavien-Dindo分类标准,术前NLI≥2.6作为早期术后并发症的预后因素,其比值比(OR)=2.24(95%置信区间[CI],1.15-4.36),由于其预测准确性低,故预后影响较小,这与之前其他报告的结果相反。术前使用化疗也被确定为术后并发症的一个危险因素。